Inovedis
Date | Investors | Amount | Round |
---|---|---|---|
* | $4.0m | Series A | |
Total Funding | AUD6.2m |
Related Content
Recent News about Inovedis
EditInovedis GmbH is a medical technology startup focused on revolutionizing rotator cuff repair procedures. Founded in 2019, the company aims to simplify surgical interventions and improve patient outcomes through its flagship product, the SINEFIX Implant System. This system is designed to enhance tendon-to-bone fixation with fewer implants and higher pull-out forces compared to traditional double-row fixation methods. The SINEFIX system eliminates the need for suture management and knot tying, making the surgical process more efficient and less complex. Inovedis primarily serves orthopedic surgeons and healthcare providers in the U.S. market, where the SINEFIX system is currently approved for use. The company operates on a B2B (business-to-business) model, generating revenue through the sale of its medical devices to hospitals and clinics. Inovedis is committed to advancing biomechanical fixation techniques to promote better biological healing and overall patient care.
Keywords: rotator cuff repair, medical technology, orthopedic surgery, tendon fixation, patient outcomes, surgical efficiency, healthcare innovation, SINEFIX system, B2B model, U.S. market.